HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Coles, J. G. Articles by Trusler, G. A. Search for Related Content PubMed PubMed Citation Articles by Coles, J. G. Articles by Trusler, G. A.

The Annals of Thoracic Surgery, Vol 38, 458-465, Copyright © 1984 by The Society of Thoracic Surgeons

ARTICLES

Surgical management of critical pulmonary stenosis in the neonate

JG Coles, RM Freedom, PM Olley, F Coceani, WG Williams and GA Trusler

Experience with 36 consecutive neonates less than 1 month of age with critical pulmonary stenosis (PS) with intact ventricular septum was analyzed to define the role of pulmonary valvotomy and of a concomitant systemic-pulmonary shunt as well as the impact of prostaglandin E1 (PGE1) therapy in the management of this disorder. Operative procedures included pulmonary valvotomy as an isolated procedure (Group 1, N = 22), pulmonary valvotomy plus a systemic-pulmonary shunt (Group 2, N = 8), pulmonary valvotomy with PGE1 therapy (Group 3, N = 5), and one miscellaneous procedure. The hospital mortality (+/- 70% confidence limits [CL]) by treatment group was as follows: Group 1, 54% (CL, 41- 67%) (12/22); Group 2, 25% (CL, 9-50%) (2/8); and Group 3, 0 (CL, 0- 32%); Group 1 versus Group 2 plus Group 3 (p less than or equal to 0.05). Patients managed with a shunt or perioperative administration of PGE1 experienced a significant improvement in early survival. Late postoperative angiography demonstrated exemplary right ventricular growth in the majority of patients, although important residual abnormalities of the outflow tract necessitating operative repair were frequently present (5-year and 10-year actuarial freedom from reoperation, 73 +/- 10% and 42 +/- 16%, respectively [+/- standard error of the mean]). This review illustrates the limitations of pulmonary valvotomy as an isolated therapeutic method in neonates with critical PS. Provision of a systemic extracardiac source of pulmonary blood flow, accomplished by a systemic-pulmonary shunt or PGE1 infusion continued postoperatively, is the most important determinant of early survival in this disorder.

This article has been cited by other articles:

				J. Wang, Y.-w. Liang, and J.-i. Hayashi Selective Annuloplasty for Tricuspid Regurgitation in Children Ann. Thorac. Surg., March 1, 2005; 79(3): 937 - 941. [Abstract] [Full Text] [PDF]

				K. R. Kanter, N. R. Doelling, D. A. Fyfe, S. Sharma, and V. K.H. Tam De Vega tricuspid annuloplasty for tricuspid regurgitation in children Ann. Thorac. Surg., October 1, 2001; 72(4): 1344 - 1348. [Abstract] [Full Text] [PDF]

				A. A. Bilkis, M. Alwi, S. Hasri, A. L. Haifa, K. Geetha, and H. I. Law Critical Pulmonary Stenosis in Infants and Neonates in the Era of Interventional Cardiology Asian Cardiovasc Thorac Ann, March 1, 1999; 7(1): 40 - 45. [Abstract] [Full Text] [PDF]

				C. Bull, M. Kostelka, K. Sorensen, and M. de Leval Outcome measures for the neonatal management of pulmonary atresia with intact ventricular septum J. Thorac. Cardiovasc. Surg., February 1, 1994; 107(2): 359 - 366. [Abstract] [Full Text]